00

Tianjin Lisheng Pharmaceutical Co LtdSHE 002393 Stock Report

Last reporting period 30 Sep, 2023

Updated 08 Nov, 2024

Last price

Market cap $B

0.559

Micro

Exchange

XSHE - Shenzhen Stock Exchange

002393.SZ Stock Analysis

00

Uncovered

Tianjin Lisheng Pharmaceutical Co Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

0.559

Dividend yield

3.51 %

Shares outstanding

183.99 B

Tianjin Lisheng Pharmaceutical Co., Ltd. principally engages in the production and sale of chemical tablets, hard capsules, drop pills, freeze-dried powder injections, water injections, and active pharmaceutical ingredients. The company is headquartered in Tianjin, Tianjin and currently employs 1,477 full-time employees. The company went IPO on 2010-04-23. The firm's major products are tablets, hard capsules, pills, free-dry powder injections, water injections and raw drugs, including drugs for cardio and cerebral vascular systems, anti-infection drugs and hormone drugs, among others. The company distributes its products mainly within domestic markets.

View Section: Eyestock Rating